IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cell Therapeutics Inc

CUSIP: 150934503 | 3 institutional holders

Quarters

Q2 2016Q1 2016Q4 2015Q3 2015Q2 2015
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2016

Vantage Investment Advisors, LLC800
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Vantage Investment Advisors, LLC
800$00.0%N/AN/AState College, PA2016-08-12